MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

DNA Tests for Early Cancer Detection

    Arrow  backGrail cancer detection

Illumina, one of the largest DNA sequencing companies, early this year announced the formation of a startup known as Grail, which plans to develop blood tests that can potentially detect many cancers for the cost of $1000 or less. The company said at the time that it hopes to make the technology available by 2019. It could be offered through a personal physician's office, or possibly through a network of testing centers.

Read the full Qmed story.

Discover how medtech is fighting Zika>>

[Image courtesy of Grail]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.